Editor’s introduction to the initial issue of the sixth volume of GaBI Journal
Pricing strategies for pharmaceuticals in developing countries: what options do we have?
Naming and labelling of biologicals – a survey of US physicians’ perspectives
Patent expiry dates for biologicals: 2016 update
Biosimilar product labels in Europe: what information should they contain?
Austrian medicines authority positive towards biosimilar interchangeability
Top developments in biosimilars during 2016
Next generation processing of monoclonal antibodies
Source URL: https://gabi-journal.net/20171-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.